keyword
https://read.qxmd.com/read/37635214/tryptophan-metabolite-norharman-secreted-by-cultivated-lactobacillus-attenuates-acute-pancreatitis-as-an-antagonist-of-histone-deacetylases
#21
JOURNAL ARTICLE
Qi Zhou, Xufeng Tao, Fangyue Guo, Yu Wu, Dawei Deng, Linlin Lv, Deshi Dong, Dong Shang, Hong Xiang
BACKGROUND: Patients with acute pancreatitis (AP) exhibit specific phenotypes of gut microbiota associated with severity. Gut microbiota and host interact primarily through metabolites; regrettably, little is known about their roles in AP biological networks. This study examines how enterobacterial metabolites modulate the innate immune system in AP aggravation. METHODS: In AP, alterations in gut microbiota were detected via microbiomics, and the Lactobacillus metabolites of tryptophan were identified by liquid chromatography-tandem mass spectrometry (LC-MS/MS)...
August 28, 2023: BMC Medicine
https://read.qxmd.com/read/37628900/the-potent-and-selective-histamine-h3-receptor-antagonist-e169-counteracts-cognitive-deficits-and-mitigates-disturbances-in-the-pi3k-akt-gsk-3%C3%AE-signaling-pathway-in-mk801-induced-amnesia-in-mice
#22
JOURNAL ARTICLE
Sabna Abdalla, Nermin Eissa, Petrilla Jayaprakash, Rami Beiram, Kamil J Kuder, Dorota Łażewska, Katarzyna Kieć-Kononowicz, Bassem Sadek
The role of histamine H3 receptors (H3Rs) in memory and the prospective of H3R antagonists in pharmacological control of neurodegenerative disorders, e.g., Alzheimer's disease (AD), is well-accepted. Therefore, the procognitive effects of acute systemic administration of H3R antagonist E169 (2.5-10 mg/kg, i.p.) on MK801-induced amnesia in C57BL/6J mice using the novel object recognition test (NORT) were evaluated. E169 (5 mg) provided a significant memory-improving effect on MK801-induced short- and long-term memory impairments in NORT...
August 12, 2023: International Journal of Molecular Sciences
https://read.qxmd.com/read/37611859/maternal-di-2-ethylhexyl-phthalate-exposure-elicits-offspring-ifn-%C3%AE-upregulation-insights-from-birth-cohort-murine-model-and-in-vitro-mechanistic-analysis
#23
JOURNAL ARTICLE
Fu-Chen Kuo, Mei-Lan Tsai, Shin-Ting Wu, Sih-Syuan Li, Chia-Fang Wu, Shu-Lin Wang, Michael W Y Chan, Jau-Ling Suen, Ming-Tsang Wu, Chih-Hsing Hung
Maternal exposure to di-(2-ethylhexyl)-phthalate (DEHP), an environmental endocrine disruptor, may lead to developmental immunotoxicity in offspring. The causal relationship and underlying mechanism require further study. A subset of Taiwan Maternal and Infant Cohort Study data (n = 283) was analyzed and found a significant association between urinary DEHP metabolite levels from the third trimester of pregnancy and plasma levels of IL-28 A and IL-29, named IFNλs, in cord blood. A trans-maternal murine model mimicking human DEHP exposure way showed that bone marrow-derived dendritic cells from maternal DEHP-exposed F1 offspring secreted higher IL-28 A levels than control cells, indicating a potential causal relationship...
August 21, 2023: Food and Chemical Toxicology
https://read.qxmd.com/read/37572216/novel-object-recognition-test-as-an-alternative-approach-to-assessing-the-pharmacological-profile-of-sigma-1-receptor-ligands
#24
JOURNAL ARTICLE
Katarzyna Szczepańska, Andrzej J Bojarski, Piotr Popik, Natalia Malikowska-Racia
BACKGROUND: Although the terms "agonist" and "antagonist" have been used to classify sigma-1 receptor (σ1 R) ligands, an unambiguous definition of the functional activity is often hard. In order to determine the pharmacological profile of σ1 R ligands, the most common method is to assess their potency to alleviate opioid analgesia. It has been well established that σ1 R agonists reduce opioid analgesic activity, while σ1 R antagonists have been demonstrated to enhance opioid analgesia in different pain models...
August 12, 2023: Pharmacological Reports: PR
https://read.qxmd.com/read/37480459/nanodelivery-of-histamine-h3-h4-receptor-modulators-bf-2649-and-clobenpropit-with-antibodies-to-amyloid-beta-peptide-in-combination-with-alpha-synuclein-reduces-brain-pathology-in-parkinson-s-disease
#25
JOURNAL ARTICLE
Anca D Buzoianu, Aruna Sharma, Dafin F Muresanu, Lianyuan Feng, Hongyun Huang, Lin Chen, Z Ryan Tian, Ala Nozari, José Vicente Lafuente, Lars Wiklund, Hari Shanker Sharma
Parkinson's disease (PD) in military personnel engaged in combat operations is likely to develop in their later lives. In order to enhance the quality of lives of PD patients, exploration of novel therapy based on new research strategies is highly warranted. The hallmarks of PD include increased alpha synuclein (ASNC) and phosphorylated tau (p-tau) in the cerebrospinal fluid (CSF) leading to brain pathology. In addition, there are evidences showing increased histaminergic nerve fibers in substantia niagra pars compacta (SNpc), striatum (STr), and caudate putamen (CP) associated with upregulation of histamine H3 receptors and downregulation of H4 receptors in human brain...
2023: Advances in Neurobiology
https://read.qxmd.com/read/37409771/grp-grpr-enhances-alcohol-associated-liver-injury-via-the-irf1-mediated-caspase-1-inflammasome-and-nox2-dependent-ros-pathway
#26
JOURNAL ARTICLE
Haidi Li, Xin Chen, Jiejie Xu, Lin Zhu, Chao Li, Xiaolong Sun, Xiaofeng Li, Jianbo Guo, Juanjuan Li, Sheng Wang, Yong He, Hua Wang, Cheng Huang, Xiaoming Meng, Jun Li
BACKGROUND AIMS: The common characteristics for alcohol-associated liver injury (ALI) include abnormal liver function, infiltration of inflammatory cells, and generation of oxidative stress. The gastrin-releasing peptide receptor (GRPR) is activated by its neuropeptide ligand, gastrin-releasing peptide (GRP). GRP/GRPR appears to induce the production of cytokines in immune cells and promotes neutrophil migration. However, the effects of GRP/GRPR in ALI are unknown. APPROACH RESULTS: We found high GRPR expression in the liver of patients with alcoholic steatohepatitis and increased pro-GRP levels in peripheral blood mononuclear cells of these patients compared to that of the control...
July 5, 2023: Hepatology: Official Journal of the American Association for the Study of Liver Diseases
https://read.qxmd.com/read/37298094/epigenetic-histone-methylation-of-ppar%C3%AE-and-cpt1a-signaling-contributes-to-betahistine-preventing-olanzapine-induced-dyslipidemia
#27
JOURNAL ARTICLE
Yueqing Su, Chao Deng, Xuemei Liu, Jiamei Lian
As a partial histamine H1 receptor agonist and H3 antagonist, betahistine has been reported to partially prevent olanzapine-induced dyslipidemia and obesity through a combination therapy, although the underlying epigenetic mechanisms are still not known. Recent studies have revealed that histone regulation of key genes for lipogenesis and adipogenesis in the liver is one of the crucial mechanisms for olanzapine-induced metabolic disorders. This study investigated the role of epigenetic histone regulation in betahistine co-treatment preventing dyslipidemia and fatty liver caused by chronic olanzapine treatment in a rat model...
May 23, 2023: International Journal of Molecular Sciences
https://read.qxmd.com/read/37242517/function-and-role-of-histamine-h-1-receptor-in-the-mammalian-heart
#28
REVIEW
Joachim Neumann, Britt Hofmann, Uwe Kirchhefer, Stefan Dhein, Ulrich Gergs
Histamine can change the force of cardiac contraction and alter the beating rate in mammals, including humans. However, striking species and regional differences have been observed. Depending on the species and the cardiac region (atrium versus ventricle) studied, the contractile, chronotropic, dromotropic, and bathmotropic effects of histamine vary. Histamine is present and is produced in the mammalian heart. Thus, histamine may exert autocrine or paracrine effects in the mammalian heart. Histamine uses at least four heptahelical receptors: H1 , H2 , H3 and H4 ...
May 11, 2023: Pharmaceuticals
https://read.qxmd.com/read/37242458/guanidines-synthesis-of-novel-histamine-h-3-r-antagonists-with-additional-breast-anticancer-activity-and-cholinesterases-inhibitory-effect
#29
JOURNAL ARTICLE
Marek Staszewski, Magdalena Iwan, Tobias Werner, Marek Bajda, Justyna Godyń, Gniewomir Latacz, Agnieszka Korga-Plewko, Joanna Kubik, Natalia Szałaj, Holger Stark, Barbara Malawska, Anna Więckowska, Krzysztof Walczyński
This study examines the properties of novel guanidines, designed and synthesized as histamine H3 R antagonists/inverse agonists with additional pharmacological targets. We evaluated their potential against two targets viz., inhibition of MDA-MB-231, and MCF-7 breast cancer cells viability and inhibition of AChE/BuChE. ADS10310 showed micromolar cytotoxicity against breast cancer cells, combined with nanomolar affinity at h H3 R, and may represent a promising target for the development of an alternative method of cancer therapy...
April 30, 2023: Pharmaceuticals
https://read.qxmd.com/read/37233887/pitolisant-pediatric-first-approval
#30
REVIEW
Susan J Keam
Pitolisant (WAKIX® ), a histamine H3 receptor antagonist/inverse agonist that has been developed by Bioprojet Pharma, is approved in the EU and USA and elsewhere for use in adults with narcolepsy with or without cataplexy. In February 2023, based on clinical data in patients aged 6 to < 18 years, pitolisant received its first approval in adolescents and children from the age of 6 years for the treatment of narcolepsy with or without cataplexy in the EU. This article summarizes the milestones in the development of pitolisant leading to this pediatric first approval for narcolepsy with or without cataplexy...
July 2023: Paediatric Drugs
https://read.qxmd.com/read/37189341/regulation-of-the-suv39h-family-methyltransferases-insights-from-fission-yeast
#31
REVIEW
Rinko Nakamura, Jun-Ichi Nakayama
Histones, which make up nucleosomes, undergo various post-translational modifications, such as acetylation, methylation, phosphorylation, and ubiquitylation. In particular, histone methylation serves different cellular functions depending on the location of the amino acid residue undergoing modification, and is tightly regulated by the antagonistic action of histone methyltransferases and demethylases. The SUV39H family of histone methyltransferases (HMTases) are evolutionarily conserved from fission yeast to humans and play an important role in the formation of higher-order chromatin structures called heterochromatin...
March 25, 2023: Biomolecules
https://read.qxmd.com/read/37171719/p19-derived-neuronal-cells-express-h-1-h-2-and-h-3-histamine-receptors-a-biopharmaceutical-approach-to-evaluate-antihistamine-agents
#32
JOURNAL ARTICLE
Mariela Gomez Perez, Georgiana Tanasie, Armelle Tchoumi Neree, Narjara Gonzalez Suarez, Clara Lafortune, Joanne Paquin, Lucia Marcocci, Paola Pietrangeli, Borhane Annabi, Mircea Alexandru Mateescu
Histamine is a biogenic amine implicated in various biological and pathological processes. Convenient cellular models are needed to screen and develop new antihistamine agents. This report aimed to characterize the response of neurons differentiated from mouse P19 embryonal carcinoma cells to histamine treatment, and to investigate the modulation of this response by antihistamine drugs, vegetal diamine oxidase, and catalase. The exposure of P19 neurons to histamine reduced cell viability to 65% maximally. This effect involves specific histamine receptors, since it was prevented by treatment with desloratadine and cimetidine, respectively, H1 and H2 antagonists, but not by the H3 antagonist ciproxifan...
May 12, 2023: Amino Acids
https://read.qxmd.com/read/37171458/amelioration-of-cognition-impairments-in-the-valproic-acid-induced-animal-model-of-autism-by-ciproxifan-a-histamine-h3-receptor-antagonist
#33
JOURNAL ARTICLE
Farahnaz Taheri, Khadijeh Esmaeilpour, Gholamreza Sepehri, Vahid Sheibani, Majid Asadi Shekari
Autism spectrum disorder is a neurodevelopmental disorder characterized by deficits in social communication and repetitive behavior. Many studies show that the number of cognitive impairmentscan be reduced by antagonists of the histamine H3 receptor (H3R). In this study, the effects of ciproxifan (CPX) (1 and 3 mg/kg, intraperitoneally) on cognitive impairments in rat pups exposed to valproic acid (VPA) (600 mg/kg, intraperitoneally) wereexamined on postnatal day 48-50 (PND 48-50) using marble-burying task (MBT), open field, novel object recognition (NOR), and Passive avoidance tasks...
June 1, 2023: Behavioural Pharmacology
https://read.qxmd.com/read/37166984/t-cell-metabolic-reprogramming-in-acute-kidney-injury-and-protection-by-glutamine-blockade
#34
JOURNAL ARTICLE
Kyungho Lee, Elizabeth A Thompson, Sepideh Gharaie, Chirag H Patel, Johanna T Kurzhagen, Phillip M Pierorazio, Lois J Arend, Ajit G Thomas, Sanjeev Noel, Barbara S Slusher, Hamid Rabb
T cells play an important role in acute kidney injury (AKI). Metabolic programming of T cells regulates their function, is a rapidly emerging field, and is unknown in AKI. We induced ischemic AKI in C57B6 mice and collected kidneys and spleens at multiple time points. T cells were isolated and analyzed by an immune-metabolic assay. Unbiased machine learning analyses identified a distinct T cell subset with reduced VDAC1 and mTOR expression in post-AKI kidneys. Ischemic kidneys showed higher expression of trimethylation of histone H3 lysine 27 (H3K27Me3) and glutaminase...
May 11, 2023: JCI Insight
https://read.qxmd.com/read/37110645/antiseizure-properties-of-histamine-h-3-receptor-antagonists-belonging-3-4-dihydroquinolin-2-1-h-ones
#35
JOURNAL ARTICLE
Yi Hua, Mingxia Song, Qiaoyue Guo, Yiqin Luo, Xianqing Deng, Yushan Huang
H3 R is becoming an attractive and promising target for epilepsy treatment as well as the discovery of antiepileptics. In this work, a series of 6-aminoalkoxy-3,4-dihydroquinolin-2(1 H )-ones was prepared to screen their H3 R antagonistic activities and antiseizure effects. The majority of the target compounds displayed a potent H3 R antagonistic activity. Among them, compounds 2a , 2c , 2h , and 4a showed submicromolar H3 R antagonistic activity with an IC50 of 0.52, 0.47, 0.12, and 0.37 μM, respectively...
April 12, 2023: Molecules: a Journal of Synthetic Chemistry and Natural Product Chemistry
https://read.qxmd.com/read/37108661/evaluation-of-some-safety-parameters-of-dual-histamine-h-3-and-sigma-2-receptor-ligands-with-anti-obesity-potential
#36
JOURNAL ARTICLE
Kamil Mika, Małgorzata Szafarz, Marek Bednarski, Agata Siwek, Katarzyna Szczepańska, Katarzyna Kieć-Kononowicz, Magdalena Kotańska
Many studies have shown the high efficacy of histamine H3 receptor ligands in preventing weight gain. In addition to evaluating the efficacy of future drug candidates, it is very important to assess their safety profile, which is established through numerous tests and preclinical studies. The purpose of the present study was to evaluate the safety of histamine H3 /sigma-2 receptor ligands by assessing their effects on locomotor activity and motor coordination, as well as on the cardiac function, blood pressure, and plasma activity of certain cellular enzymes...
April 19, 2023: International Journal of Molecular Sciences
https://read.qxmd.com/read/36927987/the-impact-of-swi-snf-and-nurd-inactivation-on-gene-expression-is-tightly-coupled-with-levels-of-rna-polymerase-ii-occupancy-at-promoters
#37
JOURNAL ARTICLE
Sachin Pundhir, Jinyu Su, Marta Tapia, Anne Meldgaard Hansen, James Seymour Haile, Klaus Hansen, Bo Torben Porse
SWI/SNF and NuRD are protein complexes that antagonistically regulate DNA accessibility. However, repression of their activities often leads to unanticipated changes in target gene expression (paradoxical), highlighting our incomplete understanding of their activities. Here we show that SWI/SNF and NuRD are in a tug-of-war to regulate PRC2 occupancy at lowly expressed and bivalent genes in mouse embryonic stem cells (mESCs). In contrast, at promoters of average or highly expressed genes, SWI/SNF and NuRD antagonistically modulate RNA polymerase II (Pol II) release kinetics, arguably owing to accompanying alterations in H3...
March 16, 2023: Genome Research
https://read.qxmd.com/read/36926339/blockade-of-endothelin-1-receptor-b-regulates-molecules-of-the-major-histocompatibility-complex-in-sickle-cell-disease
#38
JOURNAL ARTICLE
Yaritza Inostroza-Nieves, Alicia Rivera, José R Romero
Major Histocompatibility Complex (MHC) molecules have been proposed to play a role in Sickle Cell Disease (SCD) pathophysiology. Endothelial cells express MHC molecules following exposure to cytokines. SCD is characterized, in part, by vascular endothelial cell activation, increased oxidative stress, sickle cell adhesion, and excess levels of endothelin-1 (ET-1) contributing to vaso-occlusive crises. ET-1 activates endothelial cells, induces oxidative stress and inflammation, and alters erythrocyte volume homeostasis...
2023: Frontiers in Immunology
https://read.qxmd.com/read/36903593/multitargeting-histamine-h-3-receptor-ligands-among-acetyl-and-propionyl-phenoxyalkyl-derivatives
#39
JOURNAL ARTICLE
Dorota Łażewska, Maria Kaleta, Paula Zaręba, Justyna Godyń, Mariam Dubiel, Ewelina Honkisz-Orzechowska, Agata Doroz-Płonka, Anna Więckowska, Holger Stark, Katarzyna Kieć-Kononowicz
Alzheimer's disease (AD) is a neurodegenerative disorder, for which there is no effective cure. Current drugs only slow down the course of the disease, and, therefore, there is an urgent need to find effective therapies that not only treat, but also prevent it. Acetylcholinesterase inhibitors (AChEIs), among others, have been used for years to treat AD. Histamine H3 receptors (H3 Rs) antagonists/inverse agonists are indicated for CNS diseases. Combining AChEIs with H3 R antagonism in one structure could bring a beneficial therapeutic effect...
March 3, 2023: Molecules: a Journal of Synthetic Chemistry and Natural Product Chemistry
https://read.qxmd.com/read/36874957/effects-of-adjunctive-betahistine-therapy-on-lipid-metabolism-in-patients-with-chronic-schizophrenia-a-randomized-double-blind-placebo-controlled-study
#40
Luyuan Bai, Weiye Liang, Yongqian Wang, Ning Fan, Qi Zhang, Yun Bian, Fude Yang
OBJECTIVE: This study aims to explore the ability of betahistine to inhibit weight gain and abnormal lipid metabolism in patients with chronic schizophrenia. METHODS: A comparison study of betahistine or placebo therapy was conducted for 4 weeks in 94 patients with chronic schizophrenia, who were randomly divided into two groups. Clinical information and lipid metabolic parameters were collected. Positive and Negative Syndrome Scale (PANSS) was used to assess psychiatric symptoms...
2023: Neuropsychiatric Disease and Treatment
keyword
keyword
159984
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.